She was subsequently treated with subcutaneous octreotide via an insulin pump, with a continuous basal rate and additional bolus doses with meals. This led to significant improvements in hypoglycaemia ...
Zacks.com on MSN13d
Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock?TNDM's shares rise as its expanding product portfolio gains market traction. However, the unfavorable macroeconomic scenario ...
MARKHAM, Ontario, December 10, 2024--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, ...
Hosted on MSN4mon
t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM StockTandem Diabetes Care TNDM has achieved a significant milestone by gaining approval for the use of its t:slim X2 insulin pump with Eli Lilly’s ultra-rapid acting insulin, Lyumjev, in the European ...
Tandem develops its own closed-loop systems, including the t:slim X2 and Mobi pumps, which utilize Control IQ technology. San Diego-based Tandem plans to rely on UVA’s work to improve care for ...
Hosted on MSN1mon
TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in CanadaTandem Diabetes Care, Inc. TNDM announced that the in-warranty users of the t:slim X2 insulin pump in Canada can now access full compatibility with both Dexcom’s DXCM G7 and G6 Continuous ...
Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results